Interestingly, RPL13A has been reported to be stable independent of disease progression in ovarian cancer patients (n = 50; 25 normal, benign or borderline patient samples, 25 malignant epithelial tumors), and a suitable reference gene for qPCR (43). This evidence concerns the gene RPL13A and ovarian cancer.